The industry for homeopathic and anthroposophic medicinal products continues to serve the needs of each of its users

“Our products and their therapies have a clear role to play in the face of today’s health challenges in the EU. We have a responsibility to our users to ensure the continued supply of high quality and affordable products.”

In the aftermath of the pandemic, citizens have a renewed interest in health and well-being and are exploring health in all its forms. Millions of Europeans and healthcare professionals choose, use and recommend homeopathic and anthroposophic medicinal products. They do so consciously and by choice.

Today’s trends in health care open up opportunities for this sector. In its 2022 Annual Report, now available on its website, ECHAMP outlines the priorities, opportunities and challenges for the industry in the fast evolving health care environment. ECHAMP hopes that technology, data, experience, expertise, science and common sense will come together in the right way for patients.

President of ECHAMP, David Reckeweg-Lecompte explains, “Our products and their therapies have a clear role to play in the face of today’s health challenges in the EU. We have a responsibility to our users to ensure the continued supply of high quality and affordable products.” He confirms ECHAMP’s commitment to its work, saying “We keep working to ensure sufficient availability of our medicines, so that European patients can continue to access pluralism in health care and have the freedom to choose, use and benefit from these products.”

Download the Annual Report.